Is Verve Therapeutics, Inc. technically bullish or bearish?

As of 1 July 2025, the technical trend for Verve Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating some positive momentum. However, the RSI readings are bearish for both weekly and monthly periods, suggesting weakness in price strength. The Bollinger Bands are bullish weekly and mildly bullish monthly, supporting a positive outlook. Daily moving averages are bullish, and the OBV is bullish for both weekly and monthly periods, indicating accumulation. Conversely, the KST shows a bullish weekly but bearish monthly stance, and Dow Theory indicates a mildly bearish weekly trend with no trend monthly.
In terms of performance, Verve Therapeutics has outperformed the S&P 500 year-to-date with a return of 97.34% compared to 12.22%, and over the past year with a return of 57.2% against 17.14%. However, it has significantly underperformed over the 3-year period with a return of -63.64% compared to the S&P 500's 70.41%. Overall, the current technical stance is mildly bullish, driven by mixed indicators but strong year-to-date performance.